0,840  0,006  Caspase 9 stimulant
0,822  0,004  UGT1A9 substrate
0,816  0,004  Aldehyde oxidase inhibitor
0,810  0,004  UGT1A6 substrate
0,792  0,004  Tubulin antagonist
0,758  0,003  Alpha tubulin antagonist
0,746  0,003  UGT1A3 substrate
0,738  0,011  Antineoplastic (colorectal cancer)
0,733  0,011  Antineoplastic (colon cancer)
0,724  0,015  Antineoplastic (lung cancer)
0,708  0,019  Antineoplastic (breast cancer)
0,689  0,005  Antimutagenic
0,698  0,014  TNF expression inhibitor
0,668  0,003  Beta tubulin antagonist
0,672  0,007  NOS2 expression inhibitor
0,667  0,012  Prostate cancer treatment
0,685  0,033  Apoptosis agonist
0,649  0,005  Genotoxic
0,653  0,009  CTGF expression inhibitor
0,597  0,009  Free radical scavenger
0,599  0,014  5 Hydroxytryptamine release stimulant
0,585  0,004  UGT2B4 substrate
0,592  0,012  Antioxidant
0,587  0,011  Antineoplastic (non-small cell lung cancer)
0,583  0,008  Antimitotic
0,566  0,003  UGT2B15 substrate
0,568  0,007  UGT1A1 substrate
0,593  0,032  Transcription factor NF kappa B inhibitor
0,570  0,009  Amyloid beta aggregation inhibitor
0,573  0,012  Caspase 3 stimulant
0,575  0,018  Antineoplastic (ovarian cancer)
0,578  0,027  15-Lipoxygenase inhibitor
0,567  0,016  Antineoplastic (melanoma)
0,555  0,009  UDP-glucuronosyltransferase substrate
0,558  0,017  CYP1A2 substrate
0,552  0,016  Cytostatic
0,541  0,021  5 Hydroxytryptamine release inhibitor
0,534  0,014  Antineoplastic (glioma)
0,525  0,008  Peroxidase inhibitor
0,535  0,019  Antineoplastic (cervical cancer)
0,527  0,012  Hypoxia-inducible factor 1 alpha inhibitor
0,534  0,023  Antipruritic, allergic
0,519  0,008  UGT1A4 substrate
0,513  0,004  Pneumotoxic
0,518  0,018  AR expression inhibitor
0,529  0,031  CYP2C9 substrate
0,533  0,035  CYP3A4 substrate
0,531  0,042  Antineoplastic (solid tumors)
0,502  0,014  Antineoplastic (glioblastoma multiforme)
0,512  0,027  Respiratory analeptic
0,509  0,026  CYP2C19 substrate
0,492  0,014  Superoxide dismutase inhibitor
0,484  0,007  Antineoplastic (squamous cell carcinoma)
0,499  0,022  Cardioprotectant
0,478  0,004  Tyrosine 3 hydroxylase inhibitor
0,475  0,006  Amylase inhibitor
0,482  0,021  Cardiovascular analeptic
0,479  0,018  CYP1A2 inhibitor
0,490  0,030  Vasodilator, peripheral
0,458  0,006  Sulfotransferase substrate
0,473  0,023  Lipoxygenase inhibitor
0,471  0,022  Chemopreventive
0,482  0,035  Histamine release inhibitor
0,454  0,008  Topoisomerase II inhibitor
0,471  0,026  Analeptic
0,463  0,018  Antipyretic
0,442  0,011  Antineoplastic (carcinoma)
0,474  0,044  Antileukemic
0,439  0,013  Calcium channel activator
0,458  0,037  CYP2C19 inhibitor
0,446  0,025  Antineoplastic (multiple myeloma)
0,425  0,009  GST M1-1 substrate
0,436  0,021  DNA damaging
0,421  0,009  UGT2B7 substrate
0,435  0,024  Antiamyloidogenic
0,441  0,030  12-Lipoxygenase inhibitor
0,444  0,035  Antihypercholesterolemic
0,410  0,005  Cystathionine beta-synthase inhibitor
0,430  0,027  Mutagenic
0,454  0,051  GST A substrate
0,422  0,023  Tumour necrosis factor alpha release inhibitor
0,413  0,017  Antineoplastic (lymphocytic leukemia)
0,407  0,012  Antiseptic
0,446  0,053  Calcium channel L-type activator
0,409  0,017  RNA-directed DNA polymerase inhibitor
0,429  0,038  CYP2D6 substrate
0,412  0,021  Antineoplastic (renal cancer)
0,431  0,041  Bone diseases treatment
0,404  0,016  Sodium/bile acid cotransporter inhibitor
0,428  0,046  Ulceration
0,408  0,028  Proliferative diseases treatment
0,418  0,042  Teratogen
0,374  0,005  Carcinogenic, group 1
0,378  0,009  Antineoplastic (gastric cancer)
0,406  0,038  Antineoplastic (brain cancer)
0,377  0,011  Lipid peroxidase inhibitor
0,384  0,019  Abortion inducer
0,401  0,037  Antiosteoporotic
0,402  0,038  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,373  0,009  NOS3 expression enhancer
0,401  0,038  Antineoplastic (pancreatic cancer)
0,380  0,018  Antineoplastic (sarcoma)
0,394  0,035  Chemoprotective
0,377  0,018  Antineoplastic (bladder cancer)
0,370  0,012  VCAM1 expression inhibitor
0,383  0,029  Cardiodepressant
0,377  0,024  Antihypertriglyceridemic
0,358  0,007  UGT2B1 substrate
0,364  0,015  Skin whitener
0,353  0,003  UGT2B10 substrate
0,357  0,008  Glutathione S-transferase substrate
0,376  0,035  Carcinogenic
0,346  0,005  Dopamine D1 antagonist
0,438  0,100  Alpha-glucosidase inhibitor
0,353  0,016  Melanin inhibitor
0,350  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,354  0,019  Non-steroidal antiinflammatory agent
0,372  0,040  Cytotoxic
0,352  0,021  P-glycoprotein inhibitor
0,331  0,005  Topoisomerase II alpha inhibitor
0,351  0,025  5 Hydroxytryptamine uptake stimulant
0,371  0,046  Embryotoxic
0,331  0,009  Topoisomerase I inhibitor
0,332  0,011  CYP2B6 inhibitor
0,372  0,052  Hepatic disorders treatment
0,351  0,032  Nitric oxide antagonist
0,366  0,048  Spasmolytic
0,344  0,027  Cyclic AMP phosphodiesterase inhibitor
0,321  0,005  Estrogen receptor beta antagonist
0,326  0,011  Acetylcholinesterase inhibitor
0,321  0,005  LDLR expression enhancer
0,319  0,005  Estrogen antagonist
0,325  0,013  Neurotrophic factor enhancer
0,353  0,042  Sensitization
0,360  0,050  NOS3 expression inhibitor
0,339  0,032  Sigma receptor agonist
0,331  0,026  Muscle relaxant
0,340  0,036  Vasodilator
0,322  0,019  DNA methyltransferase I inhibitor
0,326  0,023  Hepatoprotectant
0,311  0,011  NADPH oxidase inhibitor
0,351  0,052  Radioprotector
0,339  0,043  Radiosensitizer
0,298  0,005  SULT1A1 substrate
0,336  0,043  Antineoplastic (small cell lung cancer)
0,419  0,128  Antiinflammatory
0,315  0,024  DNA methylase inhibitor
0,329  0,040  Pyruvate kinase inhibitor
0,329  0,040  Transcription factor STAT3 inhibitor
0,289  0,005  Estrogen agonist
0,344  0,067  Cholesterol antagonist
0,318  0,045  Antidiabetic symptomatic
0,277  0,007  VEGF expression inhibitor
0,306  0,035  Antineoplastic enhancer
0,324  0,054  Antineoplastic (osteosarcoma)
0,298  0,031  Antihypotensive
0,280  0,014  Succinate dehydrogenase inhibitor
0,343  0,085  CYP2C9 inhibitor
0,343  0,085  Prostaglandin dehydrogenase inhibitor
0,313  0,056  FMO3 substrate
0,326  0,073  FMO1 substrate
0,258  0,007  Protein kinase C zeta inhibitor
0,270  0,021  Nitric-oxide synthase stimulant
0,339  0,092  GABA C receptor rho-3 antagonist
0,301  0,055  Transcription factor STAT inhibitor
0,319  0,073  Apoptosis antagonist
0,249  0,003  Topoisomerase II beta inhibitor
0,253  0,009  Toll-Like receptor 2 antagonist
0,285  0,041  5 Hydroxytryptamine 1E antagonist
0,267  0,025  Cholinergic
0,255  0,015  SULT1A3 substrate
0,260  0,020  GST P1-1 substrate
0,317  0,078  Antithrombotic
0,256  0,019  UGT2B9 substrate
0,276  0,040  Anesthetic general
0,263  0,027  Skeletal muscle relaxant
0,257  0,023  Monophenol monooxygenase inhibitor
0,291  0,057  Antiprotozoal (Leishmania)
0,311  0,079  Vasodilator, coronary
0,238  0,005  Keratolytic
0,296  0,063  Antihypoxic
0,259  0,028  Tumour necrosis factor antagonist
0,237  0,009  Carbonic anhydrase VI inhibitor
0,314  0,086  Angiogenesis inhibitor
0,232  0,008  HIV-1 integrase (3'-Processing) inhibitor
0,229  0,005  Prolactin inhibitor
0,247  0,024  Antidote
0,278  0,057  Antineoplastic (lymphoma)
0,225  0,004  DOPA decarboxylase inhibitor
0,279  0,059  Vascular (periferal) disease treatment
0,322  0,102  Immunosuppressant
0,241  0,022  Antineoplastic (bone cancer)
0,238  0,019  Cholesterol synthesis inhibitor
0,279  0,061  Hypoglycemic
0,225  0,008  HIV-1 integrase (Strand Transfer) inhibitor
0,275  0,062  Antineoplastic (liver cancer)
0,222  0,009  Photosensitizer
0,231  0,018  Gout treatment
0,233  0,021  Antifungal enhancer
0,246  0,037  Antipruritic, non-allergic
0,217  0,009  Dopamine agonist
0,216  0,008  Creatine kinase inhibitor
0,210  0,004  UGT2B11 substrate
0,298  0,091  ICAM1 expression inhibitor
0,218  0,013  Carbonic anhydrase III inhibitor
0,220  0,017  Arachidonic acid antagonist
0,291  0,089  Antineoplastic (endocrine cancer)
0,206  0,005  Dopamine D2 agonist
0,215  0,017  Expectorant
0,206  0,009  NAD(P)H dehydrogenase (quinone) inhibitor
0,267  0,071  Flavin-containing monooxygenase substrate
0,214  0,019  Butyrylcholinesterase inhibitor
0,267  0,072  Aryl hydrocarbon receptor agonist
0,202  0,008  Estrogen receptor alpha antagonist
0,196  0,005  Estrogen receptor alpha agonist
0,216  0,025  Phobic disorders treatment
0,219  0,030  Heat shock protein 90 antagonist
0,314  0,125  Antibacterial
0,203  0,013  Protein kinase C gamma inhibitor
0,204  0,014  Antihelmintic (Trematoda)
0,212  0,023  Alkylator
0,201  0,013  Antineoplastic alkaloid
0,222  0,035  Protein kinase stimulant
0,211  0,025  Mannose-6-phosphate isomerase inhibitor
0,207  0,022  Alpha 2b adrenoreceptor antagonist
0,198  0,013  Histidine decarboxylase inhibitor
0,225  0,040  Histone acetyltransferase inhibitor
0,187  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,237  0,054  Antialcoholic
0,225  0,043  Lipocortins synthesis antagonist
0,206  0,023  5-Lipoxygenase inhibitor
0,201  0,021  CF transmembrane conductance regulator agonist
0,217  0,037  Antiparkinsonian, tremor relieving
0,204  0,025  DNA intercalator
0,199  0,021  Endometrios treatment
0,195  0,017  Coagulant
0,204  0,027  GABA C receptor rho-2 antagonist
0,193  0,017  Adenylate cyclase stimulant
0,233  0,057  Sedative
0,189  0,015  Carbonic anhydrase XIII inhibitor
0,193  0,022  Microtubule formation inhibitor
0,227  0,058  Antiviral (Influenza)
0,173  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,175  0,007  Acetylcholine release stimulant
0,183  0,015  Antineoplastic (uterine cancer)
0,207  0,040  Contraceptive
0,193  0,027  Antitussive
0,173  0,010  Postmenopausal disorders treatment
0,169  0,006  Estrogen receptor beta agonist
0,203  0,040  Neuropathy treatment
0,211  0,050  Mcl-1 antagonist
0,202  0,041  Aldehyde oxidase substrate
0,175  0,016  AMP-activated protein kinase stimulant
0,168  0,011  SULT1E1 substrate
0,196  0,040  Uterine stimulant
0,199  0,043  Toxic, respiratory center
0,177  0,023  Choleretic
0,193  0,039  Neurotensin receptor agonist
0,160  0,006  Dopamine D5 antagonist
0,180  0,027  MAP3K9 inhibitor
0,173  0,021  Contraceptive female
0,194  0,043  ATPase inhibitor
0,167  0,017  Carcinogenic, group 2A
0,168  0,019  Breast cancer-resistant protein inhibitor
0,200  0,051  Eye irritation, high
0,162  0,013  Antifungal (Pneumocystis)
0,177  0,029  Cyclooxygenase 3 inhibitor
0,151  0,005  Granulocyte macrophage colony stimulating factor agonist
0,159  0,013  Macrophage migration inhibitory factor inhibitor
0,186  0,041  Carcinogenic, group 3
0,177  0,032  Antieczematic
0,157  0,012  Aromatase inhibitor
0,165  0,020  Antiviral (Influenza B)
0,171  0,027  Xanthine oxidase inhibitor
0,185  0,041  Cyclooxygenase 1 inhibitor
0,163  0,020  Multidrug resistance-associated protein 1 inhibitor
0,291  0,148  Antiparkinsonian
0,186  0,044  Hexokinase inhibitor
0,166  0,026  Bronchodilator
0,179  0,040  M18 aspartyl aminopeptidase inhibitor
0,192  0,054  Heat shock protein 90 alpha antagonist
0,221  0,084  Angiogenesis stimulant
0,138  0,003  Dopamine D5 agonist
0,186  0,051  Hair growth stimulant
0,157  0,023  Protein kinase C mu inhibitor
0,140  0,008  SULT1A2 substrate
0,146  0,014  Tocolytic
0,154  0,022  Androgen antagonist
0,158  0,027  Ca2+-transporting ATPase inhibitor
0,152  0,022  Alpha 2a adrenoreceptor antagonist
0,170  0,039  DNA polymerase I inhibitor
0,174  0,044  Bone formation stimulant
0,159  0,029  Alpha 2c adrenoreceptor antagonist
0,247  0,118  CYP3A4 inhibitor
0,179  0,051  Interferon gamma antagonist
0,144  0,017  Paget's disease treatment
0,164  0,037  MAO A inhibitor
0,131  0,006  Estrogen-related receptor beta agonist
0,155  0,030  Mucolytic
0,133  0,009  Narcotic antagonist
0,144  0,021  Anabolic
0,137  0,014  Glutamate release inhibitor
0,147  0,025  Myasthenia Gravis treatment
0,195  0,074  Platelet adhesion inhibitor
0,153  0,031  NAT2 substrate
0,132  0,013  Aldose reductase inhibitor
0,141  0,021  Phosphodiesterase 4D inhibitor
0,154  0,035  Excitatory amino acid transporter EAAC1 inhibitor
0,153  0,035  Gastritis treatment
0,133  0,017  Glutamate decarboxylase inhibitor
0,148  0,034  Antiviral (Papilloma)
0,118  0,004  SULT2A1 substrate
0,152  0,038  Carcinogenic, group 2B
0,167  0,053  MAO inhibitor
0,157  0,044  Interleukin 4 antagonist
0,141  0,030  Alpha 2 adrenoreceptor antagonist
0,154  0,044  Antihemorrhagic
0,138  0,028  Toll-Like receptor 4 antagonist
0,163  0,054  Hemostatic
0,158  0,049  Psychosexual dysfunction treatment
0,168  0,061  Antiviral (Influenza A)
0,176  0,068  3C-like protease (Human coronavirus) inhibitor
0,112  0,004  Postcoital contraceptive
0,180  0,073  Dual specificity phosphatase 3 inhibitor
0,147  0,041  Vanilloid 1 agonist
0,196  0,090  Antiparasitic
0,121  0,015  HIV-1 integrase inhibitor
0,159  0,054  Alkaline phosphatase inhibitor
0,143  0,038  DNA repair enzyme inhibitor
0,150  0,046  Heat shock protein 70 antagonist
0,120  0,018  Glycine receptor antagonist
0,175  0,075  Antirickettsial
0,120  0,020  ATPase (Vacuolar H+) inhibitor
0,104  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,186  0,088  Insulin sensitizer
0,150  0,053  Pregnane X receptor agonist
0,100  0,005  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,146  0,052  Antihyperlipoproteinemic
0,114  0,021  CDC25A inhibitor
0,128  0,035  Sphingomyelinase inhibitor
0,147  0,055  Cocaine dependence treatment
0,127  0,035  HIV-1 integrase (Overall Integration) inhibitor
0,123  0,032  Phosphodiesterase IV inhibitor
0,241  0,150  Stroke treatment
0,133  0,043  Chelator
0,101  0,011  Heat shock protein 90 beta antagonist
0,205  0,116  DNA synthesis inhibitor
0,103  0,016  Protein kinase C eta inhibitor
0,204  0,117  Antiprotozoal (Trypanosoma)
0,094  0,008  5 Hydroxytryptamine 7 agonist
0,165  0,079  Phospholipase C inhibitor
0,162  0,076  Muscular dystrophy treatment
0,136  0,050  Papain-like protease (SARS coronavirus) inhibitor
0,103  0,017  Alcohol oxidase inhibitor
0,120  0,035  Arylamine N-Acetyltransferase substrate
0,097  0,012  Glutamate (mGluR7) antagonist
0,117  0,033  Dopamine antagonist
0,217  0,133  CYP2D6 inhibitor
0,275  0,191  Alzheimer's disease treatment
0,098  0,015  Beta 3 adrenoreceptor antagonist
0,121  0,039  GABA C receptor rho-1 antagonist
0,124  0,042  Electron transport complex I inhibitor
0,123  0,041  Chronic obstructive bronchitis treatment
0,123  0,042  Antiprotozoal (Toxoplasma)
0,194  0,114  Myocardial infarction treatment
0,104  0,024  5 Hydroxytryptamine 7 antagonist
0,150  0,070  Cyclooxygenase inhibitor
0,088  0,009  Calcium channel P-type blocker
0,123  0,044  Carbonic anhydrase XV inhibitor
0,199  0,121  Immunostimulant
0,181  0,103  Antiparkinsonian, rigidity relieving
0,141  0,063  Toll-Like receptor antagonist
0,094  0,017  Androgen agonist
0,107  0,031  Dopamine D2 antagonist
0,179  0,104  Antiviral (Ebola)
0,166  0,092  Antihelmintic
0,141  0,068  CNS active muscle relaxant
0,081  0,008  Ryanodine receptor antagonist
0,119  0,046  Urease inhibitor
0,150  0,078  Protein-tyrosine phosphatase inhibitor
0,092  0,021  MAP kinase kinase 7 inhibitor
0,119  0,048  Mediator release inhibitor
0,111  0,041  Antineoplastic antibiotic
0,168  0,098  Antiarrhythmic
0,134  0,065  Alpha-N-acetylglucosaminidase inhibitor
0,084  0,015  Carbonic anhydrase XIV inhibitor
0,156  0,087  Dual specificity phosphatase inhibitor
0,144  0,075  MAP kinase kinase 4 inhibitor
0,090  0,021  Beta adrenoreceptor antagonist
0,115  0,047  GST T1-1 substrate
0,152  0,085  Prostate disorders treatment
0,072  0,005  Melatonin 2 agonist
0,088  0,021  5 Hydroxytryptamine 2A agonist
0,092  0,026  Glycine receptor agonist
0,118  0,053  Antihelmintic (Fasciola)
0,158  0,093  Amyloid beta precursor protein antagonist
0,208  0,142  Antifungal
0,193  0,127  Interleukin agonist
0,077  0,012  Glucose-6-phosphate translocase inhibitor
0,096  0,033  Thioredoxin reductase inhibitor
0,104  0,040  Restless leg syndrome treatment
0,094  0,031  GABA aminotransferase inhibitor
0,108  0,045  Glutamate (mGluR7) agonist
0,138  0,077  Protein kinase C nu inhibitor
0,070  0,009  Liver X receptor alpha agonist
0,252  0,191  DNA polymerase beta inhibitor
0,114  0,054  GABA C receptor agonist
0,095  0,036  D-Ala-D-Ala ligase inhibitor
0,116  0,057  GABA C receptor antagonist
0,081  0,023  5 Hydroxytryptamine 5A antagonist
0,144  0,086  Aldose reductase substrate
0,129  0,071  Cyclooxygenase 2 inhibitor
0,142  0,084  Antiviral (Herpes)
0,087  0,030  Phosphodiesterase III inhibitor
0,069  0,011  Factor III inhibitor
0,082  0,025  Uterine relaxant
0,101  0,044  Antidote, mercury
0,072  0,016  DNA helicase inhibitor
0,093  0,038  Na+ K+ transporting ATPase inhibitor
0,088  0,033  Alpha adrenoreceptor agonist
0,059  0,004  Dopamine D1 agonist
0,083  0,028  Endocannabinoid uptake inhibitor
0,139  0,086  Antidiarrheal
0,093  0,042  mTOR complex 2 inhibitor
0,098  0,046  NADH dehydrogenase inhibitor
0,074  0,023  5 Hydroxytryptamine 5 antagonist
0,104  0,054  Alpha adrenoreceptor antagonist
0,121  0,070  Aldehyde dehydrogenase inhibitor
0,074  0,024  Transcription factor RelA inhibitor
0,115  0,065  TRPA1 agonist
0,093  0,043  Opioid kappa receptor antagonist
0,098  0,049  Actinic keratosis treatment
0,146  0,097  Liver fibrosis treatment
0,056  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,075  0,028  Alpha 2 adrenoreceptor agonist
0,117  0,070  Alcohol dehydrogenase substrate
0,107  0,060  Beta glucuronidase inhibitor
0,067  0,021  5 Hydroxytryptamine 2 agonist
0,079  0,033  Dopamine D3 antagonist
0,074  0,029  Antidote, heavy metal
0,201  0,156  Insulysin inhibitor
0,083  0,039  Lipase inhibitor
0,052  0,009  Melatonin agonist
0,097  0,055  Bile acid receptor antagonist
0,112  0,069  5 Hydroxytryptamine 2B antagonist
0,050  0,008  Melatonin receptor 1A agonist
0,094  0,052  Phosphodiesterase I inhibitor
0,081  0,039  GABA B receptor agonist
0,061  0,019  Squalene epoxidase inhibitor
0,108  0,066  Skin irritative effect
0,071  0,030  Xanthine dehydrogenase inhibitor
0,047  0,006  Estrogen-related receptor beta antagonist
0,054  0,014  Alpha 1d adrenoreceptor agonist
0,159  0,119  Platelet aggregation inhibitor
0,060  0,020  Potassium channel Kv1.3 blocker
0,099  0,060  MAO B inhibitor
0,061  0,022  Anesthetic inhalation
0,087  0,049  Adrenaline agonist
0,096  0,057  Alcohol dehydrogenase inhibitor
0,130  0,092  Cytidine deaminase inhibitor
0,096  0,058  Antiadrenergic
0,092  0,054  Ornithine decarboxylase inhibitor
0,075  0,038  Protein kinase C beta inhibitor
0,063  0,025  Pregnane X receptor antagonist
0,186  0,149  Antiviral (West Nile virus)
0,060  0,024  Beta 2 adrenoreceptor antagonist
0,237  0,200  DNA directed DNA polymerase inhibitor
0,066  0,030  Beta 1 adrenoreceptor antagonist
0,056  0,020  Adenylate cyclase 1 inhibitor
0,088  0,052  Myeloperoxidase inhibitor
0,077  0,042  5 Hydroxytryptamine 1A antagonist
0,092  0,058  Adrenaline antagonist
0,169  0,135  ErbB-1 antagonist
0,119  0,086  Toll-Like receptor 9 antagonist
0,045  0,012  Melatonin 1 agonist
0,131  0,098  Neuropeptide Y1 antagonist
0,125  0,092  Farnesoid X receptor antagonist
0,149  0,117  Psychostimulant
0,045  0,013  Vanilloid 3 antagonist
0,070  0,040  Glutamate (mGluR6) antagonist
0,109  0,079  Beta amyloid protein antagonist
0,128  0,099  Insulin secretagoues
0,149  0,120  I kappa B kinase epsilon inhibitor
0,063  0,033  Bcl-xL inhibitor
0,048  0,019  Progesterone antagonist
0,101  0,072  Antifungal (Aspergillus)
0,080  0,051  Antidote, organophosphates
0,106  0,079  Adenylate cyclase inhibitor
0,094  0,067  UDP-glucose 4-epimerase inhibitor
0,064  0,037  Phosphodiesterase 1B inhibitor
0,091  0,065  ABCA1 expression enhancer
0,153  0,128  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,102  0,076  Protein-tyrosine phosphatase 1B inhibitor
0,069  0,044  Exportin-1 inhibitor
0,082  0,058  CC chemokine 5 receptor agonist
0,090  0,065  Uric acid excretion stimulant
0,070  0,046  Purinergic P2X2 antagonist
0,144  0,120  Catenin beta inhibitor
0,108  0,085  Growth stimulant
0,080  0,056  Phosphodiesterase 3A inhibitor
0,055  0,031  Vanilloid 2 antagonist
0,078  0,054  Alpha 1 adrenoreceptor antagonist
0,051  0,028  Dopamine beta hydroxylase inhibitor
0,125  0,102  Acetylcholine M1 receptor antagonist
0,088  0,066  Thioredoxin inhibitor
0,039  0,017  Tubulin agonist
0,068  0,046  Leukotriene synthesis inhibitor
0,075  0,054  Antitreponemal
0,120  0,099  Antiischemic, cerebral
0,062  0,043  Phosphodiesterase 1C inhibitor
0,045  0,026  Guanylate cyclase inhibitor
0,067  0,048  Andropause treatment
0,096  0,077  Antiinfertility, female
0,038  0,019  Glucocorticoid antagonist
0,103  0,085  Aldehyde dehydrogenase substrate
0,048  0,030  Carbonic anhydrase VII inhibitor
0,067  0,049  Phenylalanine 4-hydroxylase inhibitor
0,036  0,018  Nucleoside transporters inhibitor
0,049  0,031  Antibiotic Glycopeptide-like
0,081  0,063  Antiviral (Trachoma)
0,023  0,006  NMDA receptor phencyclidine site antagonist
0,058  0,041  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,096  0,080  5 Hydroxytryptamine 3A agonist
0,118  0,103  Cell wall synthesis inhibitor
0,066  0,051  Carbonic anhydrase VA inhibitor
0,078  0,064  Antispirochetal
0,022  0,008  Ileal bile acid transport inhibitor
0,081  0,067  Opioid antagonist
0,113  0,099  Antiprotozoal (Trichomonas)
0,132  0,119  Antipruritic
0,041  0,028  Phenylethanolamine N methyltransferase inhibitor
0,055  0,042  Alpha 1 adrenoreceptor agonist
0,058  0,045  Potassium channel (Ca-activated) blocker
0,052  0,040  Leukotriene B4 antagonist
0,021  0,009  Antibiotic Anthracycline-like
0,063  0,050  Carbonic anhydrase V inhibitor
0,148  0,137  Antiulcerative
0,124  0,114  Prostatic (benign) hyperplasia treatment
0,058  0,048  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,055  0,045  Dopamine D4 antagonist
0,033  0,023  Estrogen-related receptor alpha antagonist
0,029  0,020  Liver X receptor alpha antagonist
0,028  0,018  Sigma 2 receptor antagonist
0,056  0,046  Lipocortins synthesis agonist
0,109  0,100  Antibacterial (Helicobacter pylori)
0,023  0,014  Estrone sulfatase inhibitor
0,037  0,029  Vesicle monoamine transporter inhibitor
0,032  0,024  Catechol O-methyltransferase inhibitor
0,059  0,052  Beta 2 adrenoreceptor agonist
0,042  0,036  Potassium channel small-conductance Ca-activated blocker
0,037  0,031  5 Hydroxytryptamine 2B agonist
0,056  0,049  Opioid delta receptor antagonist
0,028  0,021  Liver X receptor beta antagonist
0,030  0,024  ATP citrate lysase inhibitor
0,077  0,071  Histamine N-methyltransferase inhibitor
0,076  0,070  Inducible nitric-oxide synthase inhibitor
0,062  0,056  Alpha 1a adrenoreceptor antagonist
0,154  0,148  Antiviral (HIV)
0,058  0,053  Heme oxygenase stimulant
0,057  0,052  Antimycoplasmal
0,064  0,059  5 Hydroxytryptamine 1 antagonist
0,031  0,027  Liver X receptor beta agonist
0,062  0,059  Alpha 1b adrenoreceptor antagonist
0,039  0,035  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,018  0,015  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,051  0,048  Alpha 1d adrenoreceptor antagonist
0,066  0,063  NAT1 substrate
0,056  0,053  Transcription factor AP-1 inhibitor
0,031  0,029  Phosphoglycerate kinase inhibitor
0,055  0,053  NMDA 2C receptor antagonist
0,057  0,055  CDC25B inhibitor
0,024  0,023  Sodium/glucose cotransporter 2 inhibitor
0,030  0,029  Sodium-dependent vitamin C transporter 2 inhibitor
0,012  0,012  Melatonin receptor 1A antagonist
0,116  0,116  Antiprotozoal (Coccidial)
0,029  0,029  GABA transporter 3 inhibitor
0,008  0,008  Progesterone receptor A antagonist

